BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 29394885)

  • 1. Cortical and trabecular bone are equally affected in rats with renal failure and secondary hyperparathyroidism.
    Bajwa NM; Sanchez CP; Lindsey RC; Watt H; Mohan S
    BMC Nephrol; 2018 Feb; 19(1):24. PubMed ID: 29394885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of unfractionated heparin on renal osteodystrophy and vascular calcification in chronic kidney disease rats.
    Meng Y; Zhang H; Li Y; Li Q; Zuo L
    Bone; 2014 Jan; 58():168-76. PubMed ID: 24145307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone elongation in rats with renal failure and mild or advanced secondary hyperparathyroidism.
    Sanchez CP; He YZ; Leiferman E; Wilsman NJ
    Kidney Int; 2004 May; 65(5):1740-8. PubMed ID: 15086913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of peripheral bone and body axis skeleton in a rat model of mild-to-moderate renal failure in the presence of physiological serum levels of calcitropic hormones.
    Freesmeyer MG; Abendroth K; Faldum A; Krauss C; Stein G
    Bone; 2001 Sep; 29(3):258-64. PubMed ID: 11557370
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of osteoporosis medications in a rat model of late-stage chronic kidney disease accompanied by secondary hyperparathyroidism and hyperphosphatemia.
    Ota M; Takahata M; Shimizu T; Kanehira Y; Kimura-Suda H; Kameda Y; Hamano H; Hiratsuka S; Sato D; Iwasaki N
    Osteoporos Int; 2017 Apr; 28(4):1481-1490. PubMed ID: 27933339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rat model of SHPT with bone abnormalities in CKD induced by adenine and a high phosphorus diet.
    Ni LH; Tang RN; Lv LL; Wu M; Wang B; Wang FM; Ni HF; Song KY; Wang LT; Meng-Zuo ; Chen Q; Liu BC
    Biochem Biophys Res Commun; 2018 Apr; 498(3):654-659. PubMed ID: 29545182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathyroidism.
    Li X; Yu L; Asuncion F; Grisanti M; Alexander S; Hensley K; Han CY; Niu QT; Dwyer D; Villasenor K; Stolina M; Dean C; Ominsky MS; Ke HZ; Tomlinson JE; Richards WG
    Bone; 2017 Dec; 105():163-172. PubMed ID: 28867373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Association between Elevated Levels of Peripheral Serotonin and Its Metabolite - 5-Hydroxyindoleacetic Acid and Bone Strength and Metabolism in Growing Rats with Mild Experimental Chronic Kidney Disease.
    Pawlak D; Oksztulska-Kolanek E; Znorko B; Domaniewski T; Rogalska J; Roszczenko A; Brzóska MM; Pryczynicz A; Kemona A; Pawlak K
    PLoS One; 2016; 11(10):e0163526. PubMed ID: 27711209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moderate chronic kidney disease impairs bone quality in C57Bl/6J mice.
    Heveran CM; Ortega AM; Cureton A; Clark R; Livingston EW; Bateman TA; Levi M; King KB; Ferguson VL
    Bone; 2016 May; 86():1-9. PubMed ID: 26860048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone histomorphometry in acromegaly patients with fragility vertebral fractures.
    Dalle Carbonare L; Micheletti V; Cosaro E; Valenti MT; Mottes M; Francia G; Davì MV
    Pituitary; 2018 Feb; 21(1):56-64. PubMed ID: 29214508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptations in the Microarchitecture and Load Distribution of Maternal Cortical and Trabecular Bone in Response to Multiple Reproductive Cycles in Rats.
    de Bakker CM; Altman-Singles AR; Li Y; Tseng WJ; Li C; Liu XS
    J Bone Miner Res; 2017 May; 32(5):1014-1026. PubMed ID: 28109138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse effects of hyperphosphatemia on myocardial hypertrophy, renal function, and bone in rats with renal failure.
    Neves KR; Graciolli FG; dos Reis LM; Pasqualucci CA; Moysés RM; Jorgetti V
    Kidney Int; 2004 Dec; 66(6):2237-44. PubMed ID: 15569312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of experimental renal osteodystrophy with pamidronate.
    Jokihaara J; Pörsti IH; Kööbi P; Jolma PM; Mustonen JT; Saha HH; Sievänen H; Kannus P; Iwaniec UT; Turner RT; Järvinen TL
    Kidney Int; 2008 Aug; 74(3):319-27. PubMed ID: 18463610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered material properties are responsible for bone fragility in rats with chronic kidney injury.
    Iwasaki Y; Kazama JJ; Yamato H; Matsugaki A; Nakano T; Fukagawa M
    Bone; 2015 Dec; 81():247-254. PubMed ID: 26187196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin K(2) improves renal function and increases femoral bone strength in rats with renal insufficiency.
    Iwamoto J; Seki A; Sato Y; Matsumoto H
    Calcif Tissue Int; 2012 Jan; 90(1):50-9. PubMed ID: 22080166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferric citrate hydrate, a new phosphate binder, prevents the complications of secondary hyperparathyroidism and vascular calcification.
    Iida A; Kemmochi Y; Kakimoto K; Tanimoto M; Mimura T; Shinozaki Y; Uemura A; Matsuo A; Matsushita M; Miyamoto K
    Am J Nephrol; 2013; 37(4):346-58. PubMed ID: 23548309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.
    Lavi-Moshayoff V; Wasserman G; Meir T; Silver J; Naveh-Many T
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F882-9. PubMed ID: 20685823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc nutritional status modifies renal osteodystrophy in uremic rats.
    Kimmel PL; Langman CB; Bognar B; Faugere MC; Chawla LS; Watkins DW; Malluche HH
    Clin Nephrol; 2001 Dec; 56(6):445-58. PubMed ID: 11770796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoid-induced dose-related and site-specific bone remodelling, microstructure, and mechanical changes in cancellous and cortical bones.
    Chen Y; Zhong Z; Chen W; Lv X; Luo SY
    Clin Exp Pharmacol Physiol; 2021 Oct; 48(10):1421-1429. PubMed ID: 34214197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal insufficiency-induced bone loss is associated with an increase in bone size and preservation of strength in rat proximal femur.
    Jokihaara J; Järvinen TL; Jolma P; Kööbi P; Kalliovalkama J; Tuukkanen J; Saha H; Sievänen H; Kannus P; Pörsti I
    Bone; 2006 Aug; 39(2):353-60. PubMed ID: 16584934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.